176 related articles for article (PubMed ID: 1638511)
1. Differential stimulation of macrophages for tumor cytostasis and monokine production.
Sarih M; Souvannavong V; Adam A
Cancer Lett; 1992 Jul; 64(3):187-94. PubMed ID: 1638511
[TBL] [Abstract][Full Text] [Related]
2. Effect of interferon-gamma priming on the activation of murine peritoneal macrophages to tumouricidal state by cisplatin, IL-1, and tumour necrosis factor (TNF): production of IL-1 and TNF.
Sodhi A; Singh RK; Singh SM
Clin Exp Immunol; 1992 May; 88(2):350-5. PubMed ID: 1572101
[TBL] [Abstract][Full Text] [Related]
3. Defective production of interleukin 6 by macrophages from C3H/HeJ mice: differential stimulation of interleukin 1 and interleukin 6 induction.
Sarih M; Souvannavong V; Adam A
Immunol Lett; 1991 Sep; 30(1):69-74. PubMed ID: 1959943
[TBL] [Abstract][Full Text] [Related]
4. Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages.
Brunda MJ; Sulich V; Wright RB; Palleroni AV
Int J Cancer; 1991 Jul; 48(5):704-8. PubMed ID: 1906430
[TBL] [Abstract][Full Text] [Related]
5. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
6. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma.
Flebbe LM; Chapes SK; Morrison DC
J Immunol; 1990 Sep; 145(5):1505-11. PubMed ID: 2117032
[TBL] [Abstract][Full Text] [Related]
7. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
8. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.
Oswald IP; Wynn TA; Sher A; James SL
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8676-80. PubMed ID: 1528880
[TBL] [Abstract][Full Text] [Related]
10. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
11. Effect of interferon-gamma, tumor necrosis factor, interleukin-1 and interleukin-6 on the modulation of anti-tumor responses of bone marrow derived macrophages.
Sodhi A; Suresh A; Singh SM
Int J Immunopharmacol; 1993 Apr; 15(3):327-34. PubMed ID: 8505145
[TBL] [Abstract][Full Text] [Related]
12. Aging and eliciting agents: effect on murine peritoneal macrophage monokine bioactivity.
Chen Y; Bradley SF
Exp Gerontol; 1993; 28(2):145-59. PubMed ID: 8325351
[TBL] [Abstract][Full Text] [Related]
13. Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages.
Narumi S; Finke JH; Hamilton TA
J Biol Chem; 1990 Apr; 265(12):7036-41. PubMed ID: 2108965
[TBL] [Abstract][Full Text] [Related]
14. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
15. MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits.
Mühlradt PF; Schade U
Infect Immun; 1991 Nov; 59(11):3969-74. PubMed ID: 1937755
[TBL] [Abstract][Full Text] [Related]
16. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding AH; Nathan CF; Stuehr DJ
J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
18. Muramyldipeptide augments the actions of lipopolysaccharide in mice by stimulating macrophages to produce pro-IL-1β and by down-regulation of the suppressor of cytokine signaling 1 (SOCS1).
Shikama Y; Kuroishi T; Nagai Y; Iwakura Y; Shimauchi H; Takada H; Sugawara S; Endo Y
Innate Immun; 2011 Feb; 17(1):3-15. PubMed ID: 19897531
[TBL] [Abstract][Full Text] [Related]
19. Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.
Revelli S; Le Page C; Piaggio E; Wietzerbin J; Bottasso O
Clin Exp Immunol; 1999 Nov; 118(2):271-7. PubMed ID: 10540190
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
Drapier JC; Wietzerbin J; Hibbs JB
Eur J Immunol; 1988 Oct; 18(10):1587-92. PubMed ID: 3142779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
